sglt2 inhibitor glp 1 agonist combination GLP-1 Receptor Agonists and Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Combining glucagon-like peptide-1 receptor agonists
Description
By improving insulin sensitivity in the brain, GLP-1s could support overall cognitive function and long-term brain health
Effects of glucosedependent insulinotropic peptide on behavior
Most commonly, this means insulin through multiple daily injections or an insulin pump, though some providers use metformin as an adjunct since its generally considered safe in pregnancy
While mild to moderate nausea is expected with GLP-1 therapy, certain symptoms warrant prompt medical evaluation
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
The FDA has approved a total of 9 GLP-1RAs, with approved indications including type 2 diabetes and weight loss
NINA MOINI: That was Dr
